These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11134384)

  • 1. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.
    Chen P; Ratcliff G; Belle SH; Cauley JA; DeKosky ST; Ganguli M
    Neurology; 2000 Dec; 55(12):1847-53. PubMed ID: 11134384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.
    Chen P; Ratcliff G; Belle SH; Cauley JA; DeKosky ST; Ganguli M
    Arch Gen Psychiatry; 2001 Sep; 58(9):853-8. PubMed ID: 11545668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and test-retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer's disease.
    Thompson TA; Wilson PH; Snyder PJ; Pietrzak RH; Darby D; Maruff P; Buschke H
    Arch Clin Neuropsychol; 2011 Aug; 26(5):412-24. PubMed ID: 21613302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults.
    Gavett BE; Gurnani AS; Saurman JL; Chapman KR; Steinberg EG; Martin B; Chaisson CE; Mez J; Tripodis Y; Stern RA
    PLoS One; 2016; 11(10):e0164492. PubMed ID: 27711147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE).
    Rapp MA; Reischies FM
    Am J Geriatr Psychiatry; 2005 Feb; 13(2):134-41. PubMed ID: 15703322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.
    Maurano STP; da Silva DJ; Ávila MP; Magacho L
    Int Ophthalmol; 2018 Oct; 38(5):1839-1844. PubMed ID: 28744790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
    Wagner M; Wolf S; Reischies FM; Daerr M; Wolfsgruber S; Jessen F; Popp J; Maier W; Hüll M; Frölich L; Hampel H; Perneczky R; Peters O; Jahn H; Luckhaus C; Gertz HJ; Schröder J; Pantel J; Lewczuk P; Kornhuber J; Wiltfang J
    Neurology; 2012 Feb; 78(6):379-86. PubMed ID: 22238414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
    Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect of Multidomain Cognitive Training on the Neuropsychological Performance of Patients with Early-Stage Alzheimer's Disease.
    Nousia A; Siokas V; Aretouli E; Messinis L; Aloizou AM; Martzoukou M; Karala M; Koumpoulis C; Nasios G; Dardiotis E
    Neural Plast; 2018; 2018():2845176. PubMed ID: 30123243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological function in nondemented carriers of presenilin-1 mutations.
    Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Chavez M; Fairbanks L; Paz F; Varpetian A; Maldonado HC; Macias-Islas MA; Murrell J; Ghetti B; Kawas C
    Neurology; 2005 Aug; 65(4):552-8. PubMed ID: 16116115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.
    Kim KW; Lee DY; Jhoo JH; Youn JC; Suh YJ; Jun YH; Seo EH; Woo JI
    Dement Geriatr Cogn Disord; 2005; 19(5-6):324-30. PubMed ID: 15785033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort.
    Ramirez-Gomez L; Zheng L; Reed B; Kramer J; Mungas D; Zarow C; Vinters H; Ringman JM; Chui H
    Dement Geriatr Cogn Disord; 2017; 44(1-2):1-11. PubMed ID: 28595184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.
    Tierney MC
    Neurology; 2001 Jul; 57(1):163-4. PubMed ID: 11445658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.